Robin Augustine1,2, Alap Ali Zahid1,2, Anwarul Hasan1,2, Mian Wang3, Thomas J Webster3. 1. Department of Mechanical and Industrial Engineering, College of Engineering, Qatar University, Doha, Qatar. 2. Biomedical Research Center, Qatar University, Doha, Qatar. 3. Department of Chemical Engineering, 313 Snell Engineering Center, Northeastern University, Boston, MA 02115, USA.
Abstract
PURPOSE: Impairment of wound healing is a major issue in type-2 diabetes that often causes chronic infections, eventually leading to limb and/or organ amputation. Connective tissue growth factor (CTGF) is a signaling molecule with several roles in tissue repair and regeneration including promoting cell adhesion, cell migration, cell proliferation and angiogenesis. Incorporation of CTGF in a biodegradable core-shell fiber to facilitate its sustained release is a novel approach to promote angiogenesis, cell migration and facilitate wound healing. In this paper, we report the development of CTGF encapsulated electrospun dual porous PLA-PVA core-shell fiber based membranes for diabetic wound healing applications. METHODS: The membranes were fabricated by a core-shell electrospinning technique. CTGF was entrapped within the PVA core which was coated by a thin layer of PLA. The developed membranes were characterized by techniques such as Scanning Electron Microscopy (SEM), Fourier Transform Infrared Spectroscopy (FTIR) and X-Ray Diffraction (XRD) analysis. In vitro cell culture studies using fibroblasts, keratinocytes and endothelial cells were performed to understand the effect of CTGF loaded membranes on cell proliferation, cell viability and cell migration. A chicken chorioallantoic membrane (CAM) assay was performed to determine the angiogenic potential of the membranes. RESULTS: Results showed that the developed membranes were highly porous in morphology with secondary pore formation on the surface of individual fibers. In vitro cell culture studies demonstrated that CTGF loaded core-shell membranes improved cell viability, cell proliferation and cell migration. A sustained release of CTGF from the core-shell fibers was observed for an extended time period. Moreover, the CAM assay showed that core-shell membranes incorporated with CTGF can enhance angiogenesis. CONCLUSION: Owing to the excellent cell proliferation, migration and angiogenic potential of CTGF loaded core-shell PLA-PVA fibrous membranes, they can be used as an excellent wound dressing membrane for treating diabetic wounds and other chronic ulcers.
PURPOSE: Impairment of wound healing is a major issue in type-2 diabetes that often causes chronic infections, eventually leading to limb and/or organ amputation. Connective tissue growth factor (CTGF) is a signaling molecule with several roles in tissue repair and regeneration including promoting cell adhesion, cell migration, cell proliferation and angiogenesis. Incorporation of CTGF in a biodegradable core-shell fiber to facilitate its sustained release is a novel approach to promote angiogenesis, cell migration and facilitate wound healing. In this paper, we report the development of CTGF encapsulated electrospun dual porous PLA-PVA core-shell fiber based membranes for diabetic wound healing applications. METHODS: The membranes were fabricated by a core-shell electrospinning technique. CTGF was entrapped within the PVA core which was coated by a thin layer of PLA. The developed membranes were characterized by techniques such as Scanning Electron Microscopy (SEM), Fourier Transform Infrared Spectroscopy (FTIR) and X-Ray Diffraction (XRD) analysis. In vitro cell culture studies using fibroblasts, keratinocytes and endothelial cells were performed to understand the effect of CTGF loaded membranes on cell proliferation, cell viability and cell migration. A chicken chorioallantoic membrane (CAM) assay was performed to determine the angiogenic potential of the membranes. RESULTS: Results showed that the developed membranes were highly porous in morphology with secondary pore formation on the surface of individual fibers. In vitro cell culture studies demonstrated that CTGF loaded core-shell membranes improved cell viability, cell proliferation and cell migration. A sustained release of CTGF from the core-shell fibers was observed for an extended time period. Moreover, the CAM assay showed that core-shell membranes incorporated with CTGF can enhance angiogenesis. CONCLUSION: Owing to the excellent cell proliferation, migration and angiogenic potential of CTGF loaded core-shell PLA-PVA fibrous membranes, they can be used as an excellent wound dressing membrane for treating diabetic wounds and other chronic ulcers.
Authors: Robin Augustine; Anwarul Hasan; V K Yadu Nath; Jince Thomas; Anitha Augustine; Nandakumar Kalarikkal; Ala-Eddin Al Moustafa; Sabu Thomas Journal: J Mater Sci Mater Med Date: 2018-11-03 Impact factor: 3.896
Authors: Alap Ali Zahid; Rashid Ahmed; Syed Raza Ur Rehman; Robin Augustine; Muhammad Tariq; Anwarul Hasan Journal: Int J Biol Macromol Date: 2019-06-20 Impact factor: 6.953
Authors: Alex Carvalho Alavarse; Fernanda Waitman de Oliveira Silva; Jandir Telleria Colque; Viviam Moura da Silva; Tatiane Prieto; Everaldo Carlos Venancio; Jean-Jacques Bonvent Journal: Mater Sci Eng C Mater Biol Appl Date: 2017-03-23 Impact factor: 7.328
Authors: Maria Giovanna Gandolfi; Fausto Zamparini; Micaela Degli Esposti; Federica Chiellini; Conrado Aparicio; Fabio Fava; Paola Fabbri; Paola Taddei; Carlo Prati Journal: Mater Sci Eng C Mater Biol Appl Date: 2017-08-12 Impact factor: 7.328
Authors: Leonard Siebert; Eder Luna-Cerón; Luis Enrique García-Rivera; Junsung Oh; JunHwee Jang; Diego A Rosas-Gómez; Mitzi D Pérez-Gómez; Gregor Maschkowitz; Helmut Fickenscher; Daniela Oceguera-Cuevas; Carmen G Holguín-León; Batzaya Byambaa; Mohammad A Hussain; Eduardo Enciso-Martinez; Minsung Cho; Yuhan Lee; Nebras Sobahi; Anwarul Hasan; Dennis P Orgill; Yogendra K Mishra; Rainer Adelung; Eunjung Lee; Su Ryon Shin Journal: Adv Funct Mater Date: 2021-02-19 Impact factor: 19.924
Authors: Matej Baláž; Elena V Boldyreva; Dmitry Rybin; Stefan Pavlović; Daily Rodríguez-Padrón; Tihana Mudrinić; Rafael Luque Journal: Front Bioeng Biotechnol Date: 2021-01-27